SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

The Serum Institute of India (SII) has sought India drug regulator approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccin

Related Keywords

South Africa ,Karnataka ,India ,Chhattisgarh ,Kerala ,South African ,Adar Poonawalla ,World Health Organization ,National Expert Group On Vaccine Administration ,National Technical Advisory Group On Immunization ,Serum Institute Of India ,Shalini Bhardwajnew Delhi ,Serum Institute ,National Technical Advisory Group ,National Expert Group ,Vaccine Administration ,Chief Executive Officer ,South Africa News ,Variant ,First ,Mouth ,Micron ,Variant Was ,Group ,Covishield ,Government ,Nformed ,